Abstract:Reactive oxygen species (ROS) attract increasing interests due to the function of "double-edged sword" in physiological condition. In low concentration, ROS can benefit the growth of normal cells; however, in high concentration, they will induce cell apoptosis. Selenium is an essential trace element of human beings that can regulate the concentration of ROS. Previous work demonstrated the selective anti-cancer activity of coordinating assemblies consisting of selenium-containing amphiphile (EGSe) and cisplatin, but the structure and mechanism remain unclear. We synthesized another selenium-containing amphiphile-trimethyl-EGSe (EGSe-tMe) which has similar structure with EGSe but forms weaker interaction with platinum-containing compounds. Then, we prepared new coordinating assemblies composed of two types of selenium-containing amphiphiles and two types of platinum-containing compounds (cisplatin, platinum dichloride), in order to study the coordinating interaction between selenium and platinum. Additionally, we studied the mechanism of their selective anti-cancer activity by testing the ability of regulating ROS concentration in cancer cells and normal cells. We found that EGSe could coordinate with both cisplatin and platinum dichloride, resulting in the formation of coordinating assemblies with selective anti-cancer activity. However, coordinating assemblies consisting of EGSe-tMe and platinum-containing compounds showed little selectivity. These results indicate the important role of tight interaction between selenium and platinum played in the selective anti-cancer activity. The anti-cancer activity comes from their function of regulating the concentration of ROS in cells. Selenium-containing coordinating assemblies can raise higher concentration of ROS in cancer cells than in normal cells, thus causing selective toxicity to cancer cells. In further study, we proposed the mechanism of ROS production by selenium-containing coordinating assemblies. The coordinating assemblies can induce ROS production with the proof of electron spin resonance (ESR) measurement. We hope that this work can not only broaden the applications of selenium-containing coordinating assemblies in the field of cancer treatment, but also provide a new route for developing selective anti-cancer drugs.

Selenium-platinum coordination compounds as novel anticancer drugs: selectively killing cancer cells via a reactive oxygen species (ROS)-mediated apoptosis route.

Nanomedicine Assembled by Coordinated Selenium-Platinum Complexes Can Selectively Induce Cytotoxicity in Cancer Cells by Targeting the Glutathione Antioxidant Defense System

Selenium-containing Coordinating Assemblies with Selective Anti-cancer Activity: the Control of Reactive Oxygen Species

Breaking the Intracellular Redox Balance with Diselenium Nanoparticles for Maximizing Chemotherapy Efficacy on Patient-Derived Xenograft Models

Self-assembly Regulated Anticancer Activity of Platinum Coordinated Selenomethionine.

Selenium-Containing Amphiphiles Reduced and Stabilized Gold Nanoparticles: Kill Cancer Cells via Reactive Oxygen Species.

Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects

Amorphous ferric oxide-coating selenium core-shell nanoparticles: A self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis

Selenium-Platinum Coordination Dendrimers with Controlled Anti-Cancer Activity

Inhibition of Thioredoxin Reductase by a Novel Series of Bis-1,2-benzisoselenazol-3(2h)-ones: Organoselenium Compounds for Cancer Therapy.

Biomimetic Redox-Responsive Mesoporous Organosilica Nanoparticles Enhance Cisplatin-Based Chemotherapy

Selenium-containing metallodrug overcomes cervical cancer radioresistance by physical-chemical dual sensitization

Fast Cleavage of a Diselenide Induced by a Platinum(ii)-Methionine Complex and Its Biological Implications.

Biomimetic redox-responsive prodrug micelles with diselenide linkage for platinum nanozymes augmented sonodynamic/chemo combined therapy of colon cancer

Engineering Thio-/seleno-ether Linkers into Zwitterionic Small Molecule Nano-prodrugs for Traceable Cancer Theranostics

A Nanoscale Trans‐platinum(II)‐Based Supramolecular Coordination Self‐assembly with a Distinct Anticancer Mechanism

Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development

Diselenium-containing ultrathin polymer nanocapsules for highly efficient targeted drug delivery and combined anticancer effect

Synthesis and Potential Anticancer Activity of Some Novel Selenocyanates and Diselenides

Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo

Cytotoxicity and therapeutic effect of irinotecan combined with selenium nanoparticles.